Applied Materials AMAT0.27%increase; green up pointing triangle logged higher profit in the fiscal first quarter as artificial-intelligence computing demand soars. Profit jumped 70% to $2.03 billion, ...
Medical device company Applied Medical has been awarded $381,705,005 in damages after a federal jury in California found Medtronic liable for violations of federal and state antitrust laws. In ...
Applied Digital shares jumped after Nvidia announced a $2 billion investment in CoreWeave, a key customer of Applied Digital. The Nvidia-CoreWeave deal helps calm investor worries about whether ...
Applied Digital (APLD) continues its buildout of data centers for artificial intelligence workloads, with the latest being Delta Forge 1, a 430 MW campus located in the southern U.S. "Delta Forge 1 ...
President Trump's threats over Greenland triggered a sell-off across the market. Applied Digital's debt-heavy business model makes it especially vulnerable to potential economic slowdowns. The ...
Jan 7 (Reuters) - Applied Digital (APLD.O), opens new tab reported second-quarter revenue above Wall Street estimates on Wednesday, as the data center operator benefited from strong demand for its ...
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) stock rose Tuesday after the company disclosed a non-binding term sheet with Applied Digital Corporation (NASDAQ: APLD) for a proposed business combination ...
Applied Digital (APLD 5.22%) has been one of the best stocks to own in 2025, rising around 260% so far this year although it has been incredibly volatile, rocketing up and down since October. Applied ...
Applied Digital is downgraded to Hold after a successful Buy call, as rerating catalysts have been largely digested. APLD's hyperscaler partnerships and $11B+ in long-term leases de-risk demand, but ...
Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.
Cycle Group Holdings Limited will acquire by the pharmaceutical company Applied Therapeutics. Cycle will buy Applied for an initial price of 8.8 cents a share, Applied said Thursday. The company had ...